Then, we established Cisplatin-resistant (CDDP-R) subclones in SCC15 and UM1 cell lines respectively, and identified elevated PSMD14 in CDDP-R HNSCC cells relative to the parental ones (Figure S3). Here, PSMD14 is linked to head and neck squamous cell carcinoma.